Patents by Inventor Roberta Petrosemolo

Roberta Petrosemolo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for the treatment of MCP-1 mediated inflammatory diseases
    Patent number: 9492542
    Abstract: The present invention relates to a pharmaceutical composition comprising a combination of 1-benzyl-3-hydroxymethylindazole derivative, a pressure lowering agent selected from ACE-inhibitors, renin inhibitors, ARBs and CCBs, and/or a cholesterol lowering agent selected from statin derivatives. The combination showed an additive and synergistic activity in reducing MCP-1 levels, thus significantly improving inflammatory response inhibition and consequently reducing complications occurring in patients suffering from inflammatory diseases.
    Type: Grant
    Filed: September 3, 2010
    Date of Patent: November 15, 2016
    Assignee: AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A.
    Inventors: Angelo Guglielmotti, Beatrice Garrone, Alessandro Ble', Giuseppe Biondi, Roberta Petrosemolo, Enrica Biondi, Iacopo Biondi
  • Food formulation comprising glycogen
    Patent number: 8889654
    Abstract: The present invention relates to a food formulation for the controlled release of glucose comprising glycogen and at least one other edible component, as well the use of glycogen for its preparation.
    Type: Grant
    Filed: July 29, 2010
    Date of Patent: November 18, 2014
    Assignee: Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.
    Inventors: Vincenzo Russo, Elisa Liberati, Roberta Petrosemolo, Enrica Biondi, Iacopo Biondi
  • USE OF BENZYDAMINE IN THE TREATMENT OF P40-DEPENDENT DISEASES
    Publication number: 20120302618
    Abstract: Use of benzydamine in the treatment of inflammatory diseases, in particular Crohn's disease, rheumatoid arthritis, psoriatic arthritis, and psoriasis, caused by an expression or overexpression of the cytokine subunit p40.
    Type: Application
    Filed: June 23, 2010
    Publication date: November 29, 2012
    Applicant: AZIENDE CHIM. RIUN. ANG. FRANC. A.C.R.A.F. S.p.A.
    Inventors: Angelo Guglielmotti, Giorgina Mangano, Giuseppe Biondi, Roberta Petrosemolo, Enrica Biondi, Iacopo Biondi
  • PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MCP-1 MEDIATED INFLAMMATORY DISEASES
    Publication number: 20120220636
    Abstract: The present invention relates to a pharmaceutical composition comprising a combination of 1-benzyl-3-hydroxymethyl-indazole derivative, a pressure lowering agent selected from ACE-inhibitors, renin inhibitors, ARBs and CCBs, and/or a cholesterol lowering agent selected from statin derivatives. The combination showed an additive and synergistic activity in reducing MCP-1 levels, thus significantly improving inflammatory response inhibition and consequently reducing complications occurring in patients suffering from inflammatory diseases.
    Type: Application
    Filed: September 3, 2010
    Publication date: August 30, 2012
    Applicant: AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F.S.p.A.
    Inventors: Angelo Guglielmotti, Beatrice Garrone, Alessandro Ble', Giuseppe Biondi, Roberta Petrosemolo, Enrica Biondi, Iacopo Biondi
  • FOOD FORMULATION COMPRISING GLYCOGEN
    Publication number: 20120220547
    Abstract: The present invention relates to a food formulation for the controlled release of glucose comprising glycogen and at least one other edible component, as well the use of glycogen for its preparation.
    Type: Application
    Filed: July 29, 2010
    Publication date: August 30, 2012
    Applicant: AZIENDE CHIM. RIUN. ANG. FRANC. A.C.R.A.F. S.p.A.
    Inventors: Vincenzo Russo, Elisa Liberati, Giuseppe Biondi, Roberta Petrosemolo, Enrica Biondi, Iacopo Biondi